DNA Polymerase I Klenow Fragment [9012-90-2]

Referencia D3940-1500U

embalaje : 1500U

Marca : US Biological



D3940DNA Polymerase I Klenow Fragment

Specifications
GradeMolecular Biology Grade
Shipping TempBlue Ice
Storage Temp-20°C

DNA Polymerase I Large Fragment exhibits the 5’ ---> 3’ polymerase and 3’ ---> 5’ exonuclease activity of DNA Polymerase. Lacks 5’ ---> 3’ exonuclease activity.

Applications:
• Random primer labeling
• Sanger sequencing
• cDNA Second Strand Synthesis
• 3’ end-labeling, filling
• Blunting of DNA ends: fill-in 5'-overhangs or/and removal of 3'-overhangs, see protocol
• Oligonucleotide-directed site-specific mutagenesis.

Source:
E. coli cells with a cloned fragment of the polA gene


Storage Buffer:
Supplied as a liquid in 25mM Tris-HCl, pH 7.5, 0.1mM EDTA, 1mM DTT, 50% glycerol.

Unit Definition:
1u of DNA Polymerase I Klenow Fragment catalyzes the incorporation of 10nmoles of deoxynucleotides into polynucleotide fraction in 30 minutes at 37°C.

Reaction Buffer (Supplied):
D3940A DNA Polymerase I Klenow Fragment, Reaction Buffer, 10X:
Supplied as a liquid in 500mM Tris-HCl, pH 8.0, 50mM magnesium chloride, 10mM DTT

Inhibition and Inactivation:
• Inhibitors: metal chelators, nucleotide analogs PPi, Proprietray information (at high concentrations).
• Inactivated by heating at 75°C for 10 min or by addition of EDTA.

Quality Control:
Endodeoxyribonuclease Assay:
No detectable degradation was observed after incubation of supercoiled plasmid DNA with DNA Polymerase I Klenow Fragment.

Storage and Stability:
Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Source: E. coli cells with a cloned fragment of the polA gene|Concentration: ~10u/ul||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
References
1. C.C. Richardson, et al., J. Biol. Chem., 239:222 (1964) 2. F. Sanger, et al., Proc. Natl. Acad. Sci., 74: 5463 (1977).3. J. C. Telford, et al., Proc. Natl. Acad. Sci., 76: 2590 (1979). 4. Current Protocols in Molecular Biology, vol. 1 (Ausubel, F.M., et al., eds.), John Wiley & Sons, Inc. Brooklyn, NY, 3.5.7-3.5.10, 1994-2001. 5. Rougeon, F., et al., Nucleic Acids Res., 2:2365-2378, 1975. 6. Feinberg, et al., Anal. Biochem., 137:266-267, 1984